Nuvation Bio (NUVB) Enterprise Value (2023 - 2025)
Nuvation Bio (NUVB) has disclosed Enterprise Value for 3 consecutive years, with -$529.2 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value fell 5.28% to -$529.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$529.2 million, a 5.28% decrease, with the full-year FY2025 number at -$529.2 million, down 5.28% from a year prior.
- Enterprise Value was -$529.2 million for Q4 2025 at Nuvation Bio, up from -$549.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$461.7 million in Q1 2025 to a low of -$646.6 million in Q1 2023.
- A 3-year average of -$573.5 million and a median of -$587.1 million in 2024 define the central range for Enterprise Value.
- Biggest YoY gain for Enterprise Value was 22.66% in 2025; the steepest drop was 5.29% in 2025.
- Nuvation Bio's Enterprise Value stood at -$611.2 million in 2023, then increased by 17.76% to -$502.7 million in 2024, then dropped by 5.28% to -$529.2 million in 2025.
- Per Business Quant, the three most recent readings for NUVB's Enterprise Value are -$529.2 million (Q4 2025), -$549.0 million (Q3 2025), and -$607.7 million (Q2 2025).